Trial NCT02862535

View at ClinicalTrials.gov 
Org. Study IDs: GS-US-296-1884

Last trial update was posted on 2020-12-24

MeSH Interventions

Nivolumab Oxaliplatin

MeSH Conditions

Adenocarcinoma

Other Conditions

Gastric Adenocarcinoma

Stopping Reasons

Study was terminated due to sponsor's decision to not pursue further development of andecaliximab in oncology

Limitations And Caveats

N/A

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID